Andere Sprachen Bio-Gate AG

Aktien

BGAG98

DE000BGAG981

BIG1

Markt geschlossen - Deutsche Boerse AG Andere Börsenplätze 17:20:01 17.05.2024			% 5 Tage	% 1. Jan.
0,88 ^EUR	0,00 %		-5,38 %	-16,98 %

01.05.	Bio-Gate AG meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Bio-Gate AG meldet Ergebnis für das Halbjahr bis zum 30. Juni 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023	01.05.
Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023	29.08.23
Bio-Gate AG signs LOI with North American medical device manufacturer for trauma implants	31.07.23
Bio-Gate AG Signs LOI with North American Medical Device Manufacturer for Trauma Implants	31.07.23
Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2022	29.04.23
Bio-Gate AG Auditor Raises 'Going Concern' Doubt	29.04.23
DD: Bio-Gate AG : Notification and public disclosure of transactions by persons	05.10.22
DD: Bio-Gate AG : Notification and public disclosure of transactions by persons	05.10.22
Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2022	06.09.22
Avicanna Completes its First Commercial Export of its Derma-Cosmetics Brand Pura H&W into the European Union	08.07.22
Avicanna Inc. Completes Its First Commercial Export of Its Derma-Cosmetics Brand Pura H&WÃ– into the European Union	07.07.22
Bio Gate : concludes another cooperation agreement with leading multinational implant manufacturer	05.07.22
Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2021	07.04.22
Bio-Gate AG Auditor Raises 'Going Concern' Doubt	07.04.22
Avicanna Expands its Derma-Cosmetics Brand Pura H&W into the European Union through a Partnership with Bio-Gate AG	05.04.22
Bio-Gate Ag Reports Earnings Results for the Half Year Ended June 30, 2021	06.09.21
Bio Gate : and Avicanna complete first phase of development on Cannabidiol and Micro Silver BG™ based skin care products for global commercialization	29.06.21
Bio-Gate AG announced that it expects to receive €2.505126 million in funding	21.01.21
Bio-Gate AG Successfully Markets Antiviral and Antibacterial Protective Film Spray for Surfaces	28.10.20
Bio-Gate AG announced that it expects to receive €0.500031 million in funding	12.05.20

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Bio-Gate AG

Aktien

BGAG98

DE000BGAG981

BIG1

Andere Sprachen

Filter